कृपया अन्य खोज का प्रयास करें
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs and other related activities in the areas of oncology and hematology in Japan and internationally. It offers SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, chronic lymphocytic leukemia, and relapsed/refractory diffuse large B-cell lymphoma; SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid administrator under the TREAKISYM name. The company also engages in the development of SyB L-1101, an intravenous formulation, which completed Phase III clinical trial for the treatment of higher-risk myelodysplastic syndromes (HR-MDS); and SyB C-1101, an oral formulation that is in Phase I/II clinical trial in combination with AZA to treat HR-MDS. In addition, it is involved in the development SyB V-1901, an antiviral drug. SymBio Pharmaceuticals Limited was incorporated in 2005 and is based in Tokyo, Japan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Fuminori Yoshida | 72 | 2005 | CEO, President, Corporate Officer & Representative Director |
Toshio Heike | - | - | Member of Scientific Advisory Board |
Tatsutoshi Nakahata | - | - | Member of Scientific Advisory Board |
Tsutomu Takeuchi | - | - | Member of Scientific Advisory Board |
Makoto Ogawa | - | - | Member of Scientific Advisory Board |
Toshio Suda | - | - | Member of Scientific Advisory Board |
Shinji Nakao | - | - | Member of Scientific Advisory Board |
Robert A. Lewis | - | - | Member of Scientific Advisory Board |
Shigetoshi Matsumoto | - | 2017 | Independent Outside Director |
Kiyoshi Watanabe | 71 | 2017 | Outside Independent Director |
Kesao Endo | 71 | 2022 | Outside Independent Director |
Bruce David Cheson | - | - | Independent Outside Director |
Yasuhiro Tamo | - | 2022 | Outside Independent Director |
Eiji Ebinuma | - | - | Independent Outside Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है